Heart Failure Biomarkers—Pathophysiology, Diagnosis, Prognosis and Clinical Relevance
International Journal of Molecular Sciences · 07.10.2025 · 26 (19) · 9740
DOI: 10.3390/ijms26199740 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.10.2025. Verfasst von Bianca-Ștefania Profire und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iași, 16 University Street, 700115 Iași, Romania. Hauptthemen laut MEDLINE: Biomarkers, Heart Failure. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a complex clinical syndrome characterized by impaired cardiac function and maladaptive neurohormonal activation, representing one of the leading causes of morbidity, hospitalization, and mortality worldwide. Both its incidence and prevalence continue to rise, largely as a consequence of population aging and the increasing burden of cardiovascular risk factors. The pathogenesis of HF is multifactorial, involving a dynamic interplay between inflammation and neurohormonal activation, ultimately leading to cardiac remodeling, diastolic dysfunction, and impaired cardiac output. In this context, numerous biomarkers have been investigated for diagnosis and prognosis utility in patients with HF. According to their underlying pathophysiological mechanisms, biomarkers in HF can be broadly categorized as indicators of inflammation, oxidative stress, cardiac remodeling, myocardial stress, neurohormonal activation, and cardiomyocyte injury. This review summarizes current knowledge on the pathophysiological basis of HF and highlights the diagnostic and prognostic relevance of circulating biomarkers, emphasizing their role in linking disease mechanisms with clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iași, 16 University Street, 700115 Iași, Romania.
- Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iași, 16 University Street, 700115 Iași, Romania.
- Institute for Cardiovascular Diseases "Prof. Dr. George I.M. Georgescu", 50 Carol I Boulevard, 700503 Iași, Romania.
- "Sf. Spiridon" Clinical Emergency Hospital, 1 Independence Boulevard, 700111 Iași, Romania.
ORCID-Profile: Bianca-Ștefania Profire, Florentina Geanina Lupașcu, Cristian Stătescu, Victorița Șorodoc, Lenuța Profire
Förderung
- Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
Zitieren
APA
Profire, B. Ș., Lupașcu, F. G., Stătescu, C., Șorodoc, V., Sascău, R. A., Profire, L., & Șorodoc, L. (2025). Heart Failure Biomarkers—Pathophysiology, Diagnosis, Prognosis and Clinical Relevance. International Journal of Molecular Sciences, 26(19), 9740. https://doi.org/10.3390/ijms26199740
Vancouver
Profire BȘ, Lupașcu FG, Stătescu C, Șorodoc V, Sascău RA, Profire L, et al. Heart Failure Biomarkers—Pathophysiology, Diagnosis, Prognosis and Clinical Relevance. International Journal of Molecular Sciences. 2025;26(19):9740. doi:10.3390/ijms26199740
BibTeX
@article{Profire2025,
author = {Profire, Bianca-Ștefania and Lupașcu, Florentina Geanina and Stătescu, Cristian and Șorodoc, Victorița and Sascău, Radu-Andy and Profire, Lenuța and Șorodoc, Laurențiu},
title = {Heart Failure Biomarkers—Pathophysiology, Diagnosis, Prognosis and Clinical Relevance},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9740},
doi = {10.3390/ijms26199740}
}
EUVIMED